ATE269090T1 - Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv - Google Patents
Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hivInfo
- Publication number
- ATE269090T1 ATE269090T1 AT95905398T AT95905398T ATE269090T1 AT E269090 T1 ATE269090 T1 AT E269090T1 AT 95905398 T AT95905398 T AT 95905398T AT 95905398 T AT95905398 T AT 95905398T AT E269090 T1 ATE269090 T1 AT E269090T1
- Authority
- AT
- Austria
- Prior art keywords
- animal model
- hiv
- treat leukemia
- testing drugs
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16929393A | 1993-12-17 | 1993-12-17 | |
| PCT/US1994/014485 WO1995016452A2 (en) | 1993-12-17 | 1994-12-16 | Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269090T1 true ATE269090T1 (de) | 2004-07-15 |
Family
ID=22615057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95905398T ATE269090T1 (de) | 1993-12-17 | 1994-12-16 | Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6770260B1 (de) |
| EP (1) | EP0787003B1 (de) |
| JP (1) | JPH09506626A (de) |
| AT (1) | ATE269090T1 (de) |
| AU (1) | AU1402495A (de) |
| CA (1) | CA2174729A1 (de) |
| DE (1) | DE69433851D1 (de) |
| WO (1) | WO1995016452A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201403703XA (en) * | 2009-06-29 | 2014-10-30 | Qingfeng Chen | Methods of producing humanized non-human mammals |
| US20140256639A1 (en) * | 2013-02-14 | 2014-09-11 | The Regents Of The University Of California | Peptoid neutralizing agents |
-
1994
- 1994-12-16 EP EP95905398A patent/EP0787003B1/de not_active Expired - Lifetime
- 1994-12-16 AU AU14024/95A patent/AU1402495A/en not_active Abandoned
- 1994-12-16 DE DE69433851T patent/DE69433851D1/de not_active Expired - Lifetime
- 1994-12-16 JP JP7516956A patent/JPH09506626A/ja active Pending
- 1994-12-16 CA CA002174729A patent/CA2174729A1/en not_active Abandoned
- 1994-12-16 WO PCT/US1994/014485 patent/WO1995016452A2/en active IP Right Grant
- 1994-12-16 AT AT95905398T patent/ATE269090T1/de not_active IP Right Cessation
-
1996
- 1996-08-26 US US08/704,445 patent/US6770260B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0787003A2 (de) | 1997-08-06 |
| US6770260B1 (en) | 2004-08-03 |
| EP0787003B1 (de) | 2004-06-16 |
| DE69433851D1 (de) | 2004-07-22 |
| AU1402495A (en) | 1995-07-03 |
| WO1995016452A2 (en) | 1995-06-22 |
| JPH09506626A (ja) | 1997-06-30 |
| WO1995016452A3 (en) | 1995-10-05 |
| CA2174729A1 (en) | 1995-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
| DE3869490D1 (de) | Verfahren zur elektrochemischen behandlung von stoffen. | |
| ATA210378A (de) | Verfahren zur bekaempfung von mikroorganismen und mittel zur durchfuehrung des verfahrens | |
| ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| ATE63748T1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
| DE3884622D1 (de) | Schmiermittelzubereitung zur behandlung von rheuma. | |
| ATE192045T1 (de) | Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE198158T1 (de) | Verfahren zur behandlung geschädigter und verminderter zellen | |
| ATE170082T1 (de) | Verfahren zur wachstumshemmung von leukämischen zellen durch her-2-protein-zeilen | |
| DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
| DE3869590D1 (de) | Mischung zur behandlung von hypercholesterolemie. | |
| ATE269090T1 (de) | Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv | |
| ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
| ATE149573T1 (de) | Gerbmittel und gerbverfahren | |
| DE3674513D1 (de) | Verwendung von hygromycin und epihygromycin zur behandlung von dysentrie bei schweinen. | |
| ATA412084A (de) | Vorrichtung zur kultivierung und behandlung von biokatalysatoren | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| DE3864615D1 (de) | Verfahren und anordnung zur behandlung von bei verbrennung schadstoffe freisetzendem holz, bzw. holzkohle. | |
| DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
| DE69016249D1 (de) | Verfahren zur elektrochemischen Behandlung von Schwefelwasserstoff enthaltendem Gas. | |
| DE3680172D1 (de) | Verfahren zur behandlung von protistezellen. | |
| ATE365718T1 (de) | Substituierte 11-phenyl-dibenzazepin-verbindungen,die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten | |
| KR870007191A (ko) | 유기백금착물 및 이를 사용한 종양 치료방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |